Corcept Therapeutics (CORT) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $85.90 -6.51%
Revenue Growth %: +12.1%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
CCEL, MHGU, PLG, More
Revenue Growth %: +12.1%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of $0.20, $0.01 better than the analyst estimate of $0.19. Revenue for the quarter came in at $64.8 million versus the consensus estimate of $69.29 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- Landstar System (LSTR) PT Raised to $186 at Stifel
- Sanuwave Q2 2026 revenue tops revised guidance range
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
